BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9488465)

  • 1. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes.
    Bertolotti A; Melot T; Acker J; Vigneron M; Delattre O; Tora L
    Mol Cell Biol; 1998 Mar; 18(3):1489-97. PubMed ID: 9488465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRE elements are binding sites for the fusion protein EWS-FLI-1.
    Magnaghi-Jaulin L; Masutani H; Robin P; Lipinski M; Harel-Bellan A
    Nucleic Acids Res; 1996 Mar; 24(6):1052-8. PubMed ID: 8604338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
    Bailly RA; Bosselut R; Zucman J; Cormier F; Delattre O; Roussel M; Thomas G; Ghysdael J
    Mol Cell Biol; 1994 May; 14(5):3230-41. PubMed ID: 8164678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The splicing factor U1C represses EWS/FLI-mediated transactivation.
    Knoop LL; Baker SJ
    J Biol Chem; 2000 Aug; 275(32):24865-71. PubMed ID: 10827180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.
    Braun BS; Frieden R; Lessnick SL; May WA; Denny CT
    Mol Cell Biol; 1995 Aug; 15(8):4623-30. PubMed ID: 7623854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
    May WA; Lessnick SL; Braun BS; Klemsz M; Lewis BC; Lunsford LB; Hromas R; Denny CT
    Mol Cell Biol; 1993 Dec; 13(12):7393-8. PubMed ID: 8246959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.
    Morohoshi F; Ootsuka Y; Arai K; Ichikawa H; Mitani S; Munakata N; Ohki M
    Gene; 1998 Oct; 221(2):191-8. PubMed ID: 9795213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line.
    Dohjima T; Lee NS; Li H; Ohno T; Rossi JJ
    Mol Ther; 2003 Jun; 7(6):811-6. PubMed ID: 12788655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing.
    Yang L; Chansky HA; Hickstein DD
    J Biol Chem; 2000 Dec; 275(48):37612-8. PubMed ID: 10982800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II.
    Immanuel D; Zinszner H; Ron D
    Mol Cell Biol; 1995 Aug; 15(8):4562-71. PubMed ID: 7623847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
    Lessnick SL; Braun BS; Denny CT; May WA
    Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.
    Prieur A; Tirode F; Cohen P; Delattre O
    Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor.
    Ida K; Kobayashi S; Taki T; Hanada R; Bessho F; Yamamori S; Sugimoto T; Ohki M; Hayashi Y
    Int J Cancer; 1995 Nov; 63(4):500-4. PubMed ID: 7591257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Promoter-Associated Noncoding RNA
    Palombo R; Frisone P; Fidaleo M; Mercatelli N; Sette C; Paronetto MP
    Cancer Res; 2019 Jul; 79(14):3570-3582. PubMed ID: 31072811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gcn4p activation domain interacts specifically in vitro with RNA polymerase II holoenzyme, TFIID, and the Adap-Gcn5p coactivator complex.
    Drysdale CM; Jackson BM; McVeigh R; Klebanow ER; Bai Y; Kokubo T; Swanson M; Nakatani Y; Weil PA; Hinnebusch AG
    Mol Cell Biol; 1998 Mar; 18(3):1711-24. PubMed ID: 9488488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
    Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
    Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.
    Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH
    Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II.
    Bertolotti A; Lutz Y; Heard DJ; Chambon P; Tora L
    EMBO J; 1996 Sep; 15(18):5022-31. PubMed ID: 8890175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors.
    Zwerner JP; May WA
    Oncogene; 2001 Feb; 20(5):626-33. PubMed ID: 11313995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EWS/Fli-1 chimeric protein is a transcriptional activator.
    Ohno T; Rao VN; Reddy ES
    Cancer Res; 1993 Dec; 53(24):5859-63. PubMed ID: 7503813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.